Cargando…
Gene expression assay and Watson for Oncology for optimization of treatment in ER-positive, HER2-negative breast cancer
BACKGROUND: Personalized treatment for cancer patients is a hot topic of debate, particularly the decision to initiate chemotherapy in patients with Estrogen receptor (ER)-positive, HER2-negative tumors in the early stages of breast cancer (BC). Owing to significant advancements in information techn...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6034851/ https://www.ncbi.nlm.nih.gov/pubmed/29979736 http://dx.doi.org/10.1371/journal.pone.0200100 |